Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Other Working Capital Changes (2020 - 2025)

Biofrontera has reported Other Working Capital Changes over the past 6 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $1.2 million for Q4 2025, up 604.0% from a year ago — trailing twelve months through Dec 2025 was $686000.0 (up 386.52% YoY), and the annual figure for FY2025 was $686000.0, up 386.52%.
  • Other Working Capital Changes for Q4 2025 was $1.2 million at Biofrontera, up from -$175000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for BFRIW hit a ceiling of $4.0 million in Q4 2021 and a floor of -$3.6 million in Q1 2022.
  • Median Other Working Capital Changes over the past 5 years was -$15500.0 (2021), compared with a mean of $184050.0.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 2508.39% in 2021 and later tumbled 4454.22% in 2022.
  • Biofrontera's Other Working Capital Changes stood at $4.0 million in 2021, then dropped by 17.39% to $3.3 million in 2022, then plummeted by 94.82% to $173000.0 in 2023, then rose by 1.16% to $175000.0 in 2024, then surged by 604.0% to $1.2 million in 2025.
  • The last three reported values for Other Working Capital Changes were $1.2 million (Q4 2025), -$175000.0 (Q3 2025), and -$595000.0 (Q2 2025) per Business Quant data.